• 1
    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine JE, Müller-lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (Suppl): II437.
  • 2
    Kennedy TM, Jones RH, Hungin AP, O'Flanagan H, Kelly P. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998; 43: 7704.
  • 3
    Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol 2000; 95: 143947.
    Direct Link:
  • 4
    Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1996; 110: 96970.
  • 5
    Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000; 62: 6672.
  • 6
    Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and non-patients with irritable bowel syndrome. Gastroenterology 1988; 95: 7018.
  • 7
    Janssen HA, Muris JW, Knotterus JA. The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review. Scand J Gastroenterol 1998; 33: 5617.
  • 8
    Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defecation in the irritable bowel syndrome. Patients’ description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 41521.
  • 9
    Mearin F, Baró E, Roset M, Badía X, Zárate N, Perez I. Clinical patterns over time in Irritable Bowel Syndrome: symptom instability and severity variability. Am J Gastroenterol 2004; 99: 11321.
    Direct Link:
  • 10
    Heaton KW, Ghosh S, Braddon FEM. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991; 32: 739.
  • 11
    Stevens JA, Wan CK, Blanchard EB. The short natural history of irritable bowel syndrome: a time-series analysis. Behav Res Ther 1997; 35: 31926.
  • 12
    Hahn B, Watson M, Yan S, et al. Irritable bowel syndrome symptom patterns. Frequency, duration and severity. Dig Dis Sci 1998; 43: 271518.
  • 13
    Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome. Systematic review. Am J Gastroenterol 2005; 100: 117484.
    Direct Link:
  • 14
    Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II vs. previous criteria in a general population. Scand J Gastroenterol 2001; 36: 115561.
  • 15
    Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17: 64350.
  • 16
    Waller SI, Misciewicz JJ. Prognosis in the irritable bowel syndrome. Lancet 1969; 2: 7536.
  • 17
    Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 16577.
  • 18
    Harvey RF, Brown AM, Mauad EC. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987; 1: 9635.
  • 19
    Svendsen JH, Munck LK, Andersen JR. Irritable bowel syndrome: prognosis and diagnostic safety. A 5-year follow up study. Scand J Gastroenterol 1985; 20: 4158.
  • 20
    Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994; 236: 2330.
  • 21
    Holmes KM, Salter RH. Irritable bowel syndrome. A safe diagnosis. BMJ 1982; 285: 15334.
  • 22
    Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122: 10712.
  • 23
    O'Donnell LJD, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. Br Med J 1990; 300: 43940.
  • 24
    Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 54752.
  • 25
    Patrick DL, Drossman DA, Frederick IO, Dicesare J, Puder KL. Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 1998; 43: 40011.
  • 26
    Badia X, Herdman M, Mearin F, Perez I. Adaptación al español del cuestionario IBSQOL para la medición de la calidad de vida en pacientes con síndrome del intestino irritable. Rev Esp Enf Dig 2000; 92: 63743.
  • 27
    EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199208.
  • 28
    Badia X, Roset M, Montserrat S, Herdman M, Segura A. La version española del EuroQol: descripción y aplicaciones. Med Clin (Barc) 1999; 112: 7986.
  • 29
    Badia X, Gutierrez F, Wiklund I, Alonso J. Validity and reliability of the Spanish version of the Psychological General Well-Being Index. Qual Life Res 1996; 5: 1018.
  • 30
    Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 114056.
  • 31
    El-Serag HB, Pilgrim P, Schoenfeld P. Systemic review: natural history of irritable bowel syndrome.Aliment Pharmacol Ther 2004; 19: 86170.
  • 32
    Mearin F, Balboa A, Badia X, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003; 15: 16572.
  • 33
    Whitehead WE, Levy RL, Von Korff M, et al. The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20: 130515.
  • 34
    Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome: defining an alternator. Gastroenterology 2005; 128: 5809.
  • 35
    Badia X, Mearin F, Balboa A, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002; 20: 74958.
  • 36
    Piccirillo G, Viola E, Nocco M, et al. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertension 1999; 34: 2426.
  • 37
    Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med 1996; 335: 17681.
  • 38
    Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 3740.
  • 39
    Kalantar JS, Locke GR III, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ III. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther 2003; 17: 138997.